STOCK TITAN

[Form 4] JPMORGAN CHASE & CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Stephen B. Burke, a director of JPMORGAN CHASE & CO, reported a transaction dated 09/30/2025 on Form 4 showing a non-derivative acquisition of 178.328 shares of common stock at a price of $315.43 per share. Following the reported transaction, Mr. Burke beneficially owns 184,880.6865 shares directly and an additional 75,000 shares indirectly through a GRAT. The filing notes the shares stem from a deferral of a quarterly director retainer, with the retainer payable in common stock following termination of director service. The form is signed under power of attorney on 10/01/2025.

Stephen B. Burke, dirigente di JPMORGAN CHASE & CO, ha riportato una operazione datata 30/09/2025 sul modulo 4 che mostra un'acquisizione non derivativa di 178,328 azioni ordinarie al prezzo di 315,43 dollari per azione. A seguito dell'operazione, il signor Burke detiene direttamente 184.880,6865 azioni e altre 75.000 azioni in modo indiretto tramite un GRAT. La dichiarazione indica che le azioni derivano da un
rinvio del compenso trimestrale da consigliere, con il compenso pagabile in azioni comuni al termine del mandato da consigliere. Il modulo è firmato con procura il 01/10/2025.

Stephen B. Burke, director de JPMORGAN CHASE & CO, reportó una operación con fecha 30/09/2025 en el Formulario 4 que muestra una adquisición no derivativa de 178,328 acciones ordinarias a un precio de 315,43 dólares por acción. Tras la operación, el Sr. Burke posee directamente 184.880,6865 acciones y, de forma indirecta a través de un GRAT, otras 75.000 acciones. La declaración indica que las acciones provienen de un aplazamiento del compensate trimestral de director, que se paga en acciones comunes al finalizar el mandato como director. El formulario se firma bajo poder notarial el 01/10/2025.

Stephen B. Burke은 JPMORGAN CHASE & CO의 이사로서 2025년 9월 30일자로 Form 4에 비파생적 주식 취득을 보고했으며, 주당 315.43달러에 178,328주를 취득했습니다. 보고된 거래 이후 Burke 씨는 직접 184,880.6865주를 보유하고 있으며, GRAT를 통해 간접적으로 추가로 75,000주 보유합니다. 신고서에는 이 주식이 분기 이사회 보수의 연기에서 비롯되었고, 보수는 이사회 서비스 종료 후 보통주로 지급된다고 적혀 있습니다. 해당 양식은 2025년 10월 1일에 위임장으로 서명되었습니다.

Stephen B. Burke, administrateur de JPMORGAN CHASE & CO, a signalé une opération datant du 30/09/2025 sur le formulaire 4 montrant une acquisition non dérivée de 178 328 actions ordinaires à un prix de 315,43 dollars par action. Suite à l'opération, M. Burke détient directement 184 880,6865 actions et 75 000 actions supplémentaires indirectement via un GRAT. Le dossier précise que les actions proviennent d'un décalage du rémunération trimestrielle de directeur, rémunération payable en actions ordinaires après la fin du mandat de directeur. Le formulaire est signé sous procuration le 01/10/2025.

Stephen B. Burke, Direktor von JPMORGAN CHASE & CO, meldete eine Transaktion mit dem Datum 30.09.2025 im Formular 4, die einen nicht derivativen Erwerb von 178.328 Stammaktien zu einem Preis von 315,43 USD pro Aktie zeigt. Nach der gemeldeten Transaktion besitzt Herr Burke direkt 184.880,6865 Aktien und zusätzlich 75.000 Aktien indirekt über einen GRAT. Die Einreichung vermerkt, dass die Aktien aus einer Verschiebung einer vierteljährlichen Vorstandsvergütung stammen, die nach Beendigung des Vorstandsmandats in Stammaktien gezahlt wird. Das Formular ist am 01.10.2025 unter Vollmacht unterschrieben.

Stephen B. Burke، مدير في JPMORGAN CHASE & CO، أبلغ عن صفقة بتاريخ 30/09/2025 في النموذج 4 تُظهر استحواذًا غير مشتق على 178,328 سهماً من الأسهم العادية بسعر 315.43 دولار للسهم. عقب الصفقة، يمتلك السيد Burke بشكل مباشر 184,880.6865 سهماً وبشكل غير مباشر من خلال GRAT إضافية 75,000 سهماً. وتذكر الإفادة أن الأسهم ناتجة عن تأجيل أجر المدير الربعي، الذي يُدفع في شكل أسهم عادية عند انتهاء خدمة المدير. النموذج موقع بموجب تفويض في 01/10/2025.

Stephen B. Burke,JPMORGAN CHASE & CO 的董事,已在 Form 4 上报告了一笔日期为 2025/09/30 的交易,显示以非衍生方式取得 178.328 股普通股,价格为每股 315.43 美元。交易后,Burke 先生直接持有 184,880.6865 股,并通过 GRAT 间接持有额外的 75,000 股。披露指出这些股份来自季度董事报酬的递延,报酬在董事服务结束后以普通股支付。该表格于 2025/10/01 在代理授权下签署。

Positive
  • Director increased direct beneficial ownership to 184,880.6865 shares following the acquisition
  • Disclosure of indirect holdings (75,000 shares held by a GRAT) improves transparency
Negative
  • None.

Insights

TL;DR: A routine director compensation deferral increases direct ownership and discloses indirect holdings via a GRAT.

The Form 4 discloses a standard compensation-in-stock deferral by a sitting director rather than an open-market purchase, which aligns long-term director compensation with shareholder equity without indicating market timing. The combination of direct ownership (184,880.6865 shares) and a 75,000-share GRAT position shows concentrated insider exposure to the issuer's stock. This is a governance transparency item rather than a material operational development.

TL;DR: Transaction reflects compensation mechanics; no evidence of market-significant insider buying or selling.

The report documents acquisition of 178.328 shares at $315.43 via a director retainer deferral, not an open-market trade, and lists substantial beneficial ownership levels. For investors, the filing confirms insider alignment through equity compensation but contains no new operational or financial metrics to change valuation models.

Stephen B. Burke, dirigente di JPMORGAN CHASE & CO, ha riportato una operazione datata 30/09/2025 sul modulo 4 che mostra un'acquisizione non derivativa di 178,328 azioni ordinarie al prezzo di 315,43 dollari per azione. A seguito dell'operazione, il signor Burke detiene direttamente 184.880,6865 azioni e altre 75.000 azioni in modo indiretto tramite un GRAT. La dichiarazione indica che le azioni derivano da un
rinvio del compenso trimestrale da consigliere, con il compenso pagabile in azioni comuni al termine del mandato da consigliere. Il modulo è firmato con procura il 01/10/2025.

Stephen B. Burke, director de JPMORGAN CHASE & CO, reportó una operación con fecha 30/09/2025 en el Formulario 4 que muestra una adquisición no derivativa de 178,328 acciones ordinarias a un precio de 315,43 dólares por acción. Tras la operación, el Sr. Burke posee directamente 184.880,6865 acciones y, de forma indirecta a través de un GRAT, otras 75.000 acciones. La declaración indica que las acciones provienen de un aplazamiento del compensate trimestral de director, que se paga en acciones comunes al finalizar el mandato como director. El formulario se firma bajo poder notarial el 01/10/2025.

Stephen B. Burke은 JPMORGAN CHASE & CO의 이사로서 2025년 9월 30일자로 Form 4에 비파생적 주식 취득을 보고했으며, 주당 315.43달러에 178,328주를 취득했습니다. 보고된 거래 이후 Burke 씨는 직접 184,880.6865주를 보유하고 있으며, GRAT를 통해 간접적으로 추가로 75,000주 보유합니다. 신고서에는 이 주식이 분기 이사회 보수의 연기에서 비롯되었고, 보수는 이사회 서비스 종료 후 보통주로 지급된다고 적혀 있습니다. 해당 양식은 2025년 10월 1일에 위임장으로 서명되었습니다.

Stephen B. Burke, administrateur de JPMORGAN CHASE & CO, a signalé une opération datant du 30/09/2025 sur le formulaire 4 montrant une acquisition non dérivée de 178 328 actions ordinaires à un prix de 315,43 dollars par action. Suite à l'opération, M. Burke détient directement 184 880,6865 actions et 75 000 actions supplémentaires indirectement via un GRAT. Le dossier précise que les actions proviennent d'un décalage du rémunération trimestrielle de directeur, rémunération payable en actions ordinaires après la fin du mandat de directeur. Le formulaire est signé sous procuration le 01/10/2025.

Stephen B. Burke, Direktor von JPMORGAN CHASE & CO, meldete eine Transaktion mit dem Datum 30.09.2025 im Formular 4, die einen nicht derivativen Erwerb von 178.328 Stammaktien zu einem Preis von 315,43 USD pro Aktie zeigt. Nach der gemeldeten Transaktion besitzt Herr Burke direkt 184.880,6865 Aktien und zusätzlich 75.000 Aktien indirekt über einen GRAT. Die Einreichung vermerkt, dass die Aktien aus einer Verschiebung einer vierteljährlichen Vorstandsvergütung stammen, die nach Beendigung des Vorstandsmandats in Stammaktien gezahlt wird. Das Formular ist am 01.10.2025 unter Vollmacht unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BURKE STEPHEN B

(Last) (First) (Middle)
383 MADISON AVENUE

(Street)
NEW YORK NY 10179-0001

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
JPMORGAN CHASE & CO [ JPM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2025 A(1) 178.328 A $315.43 184,880.6865 D
Common Stock 75,000 I By GRAT
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Deferral of quarterly retainer, payable in common stock following termination of service as director.
/s/ Holly Youngwood under POA 10/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for AMJB / JPM report for Stephen B. Burke?

The Form 4 reports a 09/30/2025 acquisition of 178.328 common shares at $315.43 and shows 184,880.6865 shares owned directly plus 75,000 indirectly via a GRAT.

Why were the shares issued to Stephen B. Burke according to the filing?

The filing explains the shares arose from a deferral of a quarterly director retainer, payable in common stock following termination of director service.

Does the Form 4 indicate open-market trading by the director for AMJB / JPM?

No. The transaction code and explanation indicate the shares were received as a compensation deferral, not an open-market purchase or sale.

Who signed the Form 4 and when was it signed?

The form is signed by Holly Youngwood under POA on 10/01/2025.

What is the nature of the 75,000 shares listed in the filing?

The filing identifies the 75,000 shares as held indirectly through a Grantor Retained Annuity Trust (GRAT).
Alerian MLP Index ETN

NYSE:AMJB

AMJB Rankings

AMJB Latest News

AMJB Latest SEC Filings

AMJB Stock Data

23.44M
National Commercial Banks
NEW YORK